Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson's disease

Movement Disorders

Volumn 29, Issue 9, 2014, Pages 1205-1208

  Lee, Eun Young ^a   Eslinger, Paul J ^a   Du, Guangwei ^a   Kong, Lan ^a   Lewis, Mechelle M ^a   Huang, Xuemei ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

MRI; Olfaction; Olfactory cortex; Parkinson's disease; Voxel based morphometry

Indexed keywords

AGED; ATROPHY; BRAIN CORTEX; COMPLICATION; FEMALE; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OLFACTION DISORDERS; PARKINSON DISEASE; PATHOLOGY; SEVERITY OF ILLNESS INDEX; STATISTICS;

AGED; ATROPHY; CEREBRAL CORTEX; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OLFACTION DISORDERS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; STATISTICS AS TOPIC;

EID: 84906081927     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25829     Document Type: Article

References (31)

1. Hoyles K, Sharma JC. Olfactory loss as a supporting feature in the diagnosis of Parkinson's disease: a pragmatic approach. J Neurol 2013;260:2951-2958.
2. Bohnen NI, Muller ML, Kotagal V, et al. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain 2010;133:1747-1754.
3. Wattendorf E, Welge-Luessen A, Fiedler K, et al. Olfactory impairment predicts brain atrophy in Parkinson's disease. J Neurosci 2009;29:15410-15413.
4. Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
5. Brodoehl S, Klingner C, Volk GF, Bitter T, Witte OW, Redecker C. Decreased olfactory bulb volume in idiopathic Parkinson's disease detected by 3.0-Tesla magnetic resonance imaging. Mov Disord 2012;27:1019-1025.
6. Wu X, Yu C, Fan F, et al. Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson's disease. Eur Neurol 2011;66:98-105.
7. Mueller A, Abolmaali N, Hakimi A, et al. Olfactory bulb volumes in patients with idiopathic Parkinson's disease a pilot study. J Neural Transm 2005;112:1363-1370.
8. Lee JE, Cho KH, Ham JH, Song SK, Sohn YH, Lee PH. Olfactory performance acts as a cognitive reserve in non-demented patients with Parkinson's disease. Parkinsonism Relat Disord 2013 Nov 4. doi: 10.1016/j.parkreldis.2013.10.024.
9. Calne D, Snow B, Lee C. Criteria for diagnosing Parkinson's disease. Ann Neurol 1992;32:S125-S127.
10. Clarke CE. Neuroprotection and pharmacotherapy for motor symptoms in Parkinson's disease. Lancet Neurol 2004;3:466-474.
11. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
13. Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results. Mov Disord 2008;23:2129-2170.
14. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
15. Doty RL, Shaman P, Kimmelman CP, Dann MS. University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 1984;94:176-178.
16. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(Suppl):S208-S219.
17. Feldmann A, Illes Z, Kosztolanyi P, et al. Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study. Mov Disord 2008;23:42-46.
18. Lee EY, Sen S, Eslinger PJ, et al. Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients. Parkinsonism Relat Disord 2013;19:1088-1093.
19. Anderson AK, Christoff K, Stappen I, et al. Dissociated neural representations of intensity and valence in human olfaction. Nature Neurosci 2003;6:196-202.
20. Gottfried JA, Zald DH. On the scent of human olfactory orbitofrontal cortex: meta-analysis and comparison to non-human primates. Brain Res Rev 2005;50:287-304.
21. Li W, Luxenberg E, Parrish T, Gottfried JA. Learning to smell the roses: experience-dependent neural plasticity in human piriform and orbitofrontal cortices. Neuron 2006;52:1097-1108.
22. Sobel N, Prabhakaran V, Zhao Z, et al. Time course of odorant-induced activation in the human primary olfactory cortex. J Neurophysiol 2000;83:537-551.
23. Baba T, Kikuchi A, Hirayama K, et al. Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain 2012;135:161-169.
24. Plailly J, Bensafi M, Pachot-Clouard M, et al. Involvement of right piriform cortex in olfactory familiarity judgments. Neuroimage 2005;24:1032-1041.
25. Royet JP, Plailly J, Delon-Martin C, Kareken DA, Segebarth C. fMRI of emotional responses to odors: influence of hedonic valence and judgment, handedness, and gender. Neuroimage 2003;20:713-728.
26. Strauss GP, Allen DN, Ross SA, Duke LA, Schwartz J. Olfactory hedonic judgment in patients with deficit syndrome schizophrenia. Schizophr Bull 2010;36:860-868.
27. Assogna F, Cravello L, Caltagirone C, Spalletta G. Anhedonia in Parkinson's disease: a systematic review of the literature. Mov Disord 2011;26:1825-1834.
28. Haber S, Kunishio K, Mizobuchi M, Lynd-Balta E. The orbital and medial prefrontal circuit through the primate basal ganglia. J Neurosci 1995;15:4851-4867.
29. Levy R, Dubois B. Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 2006;16:916-928.
30. Schultz W, Tremblay L, Hollerman JR. Reward processing in primate orbitofrontal cortex and basal ganglia. Cereb Cortex 2000;10:272-284.
31. Doty, RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38:1237-1244.